SCOR: Second quarter 2026 results: EUR 171 million net income in Q2 2026, contributing to a net income of EUR 397 million in H1 2026

SCOR SE reported Q2 2026 net income of EUR 171 million (EUR 188 million adjusted), bringing H1 2026 net income to EUR 397 million. P&C combined ratio was 79.5% and L&H insurance service result was EUR 49 million. Investments regular income yield was 3.6%. Solvency ratio was estimated at 220%.

Original reporting
Published Jul 30, 2026, 6:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 6:59 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SCOR
Bullish
medium confidence
Mentioned
$SCOR
Relevance
8/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$SCORBullishMed
01

Why it matters

The release combines profitability (net income, combined ratio, ISR) with balance-sheet/capital strength (IFRS 17 Economic Value, solvency ratio), which can influence valuation and risk appetite for reinsurance exposure.

02

Market read

Traders can update expectations for SCOR’s underwriting performance and capital generation into H2 2026 based on the reported profitability and solvency datapoints.

03

What to watch

L&H insurance service result is affected by a one-off arbitration outcome; investors may discount the adjusted ISR and scrutinize experience variance sustainability.

Relevance 8/10Novelty 8/10Timing: post-release, ahead of next analyst revisions and FY 2026 expectation updates

Background

SCOR’s Board approved Q2 2026 financial statements on 29 July 2026, reporting results across P&C, L&H, and Investments under IFRS 17 metrics.

Company-level read

Ticker impact

$SCORBullishMedium confidence
Context

SCOR reported Q2 2026 net income of EUR 171 million, with P&C combined ratio 79.5% and solvency ratio estimated at 220%.

Expected impact

Likely positive bias for SCOR shares, with focus on combined ratio durability and solvency trajectory.

Evidence & confidence

The release provides multiple decision-useful datapoints (net income, combined ratio, investment yield, solvency) and references alignment with FY 2026 guidance, which can drive re-rating versus prior expectations.

Market effects

Reinsurance peers may see read-across on underwriting discipline, natural catastrophe sensitivity, and capital strength metrics.

Primarily European insurance sentiment, with potential spillover to European reinsurance capital markets.

Limited direct global macro linkage, but reinforces global reinsurance profitability and solvency narratives.

Counterpoint

Benign natural catastrophe experience (low Nat Cat ratio) may not persist, so the strong combined ratio could mean-revert.

Key entities

  • SCOR SE

    Reported Q2 2026 net income of EUR 171 million, P&C combined ratio 79.5%, and estimated solvency ratio of 220%.

Related articles

$SCORMed

Why is SCOR stock rallying today? By Investing.com

SCOR SE shares rose about 3.5% to 34.58 on Euronext Paris after the company reported Q2 2026 results. SCOR posted net income of EUR 171 million in Q2 and EUR 397 million for the first half, with a property and casualty combined ratio of 79.5%. Morgan Stanley named SCOR a preferred European insurance pick, citing potential capital release from Solvency II changes in Jan 2027.

$SCORMed

SCOR reports 24% drop in second quarter net income By Investing.com

SCOR SE reported Q2 net income of EUR 171 million, down 24% year over year, with insurance revenue down 5.1%. The property and casualty combined ratio improved to 79.5% on lower catastrophe losses and better attritional performance. Life and health service result was hurt by a one-off arbitration outcome. SCOR posted EUR 397 million net income in H1 2026 and expects continued competitive P&C reinsurance conditions.

$SCORMedAI 9/10

SCOR successfully places EUR 500 million subordinated notes maturing in 2056

SCOR SE said it has placed EUR 500 million fixed-to-floating rate subordinated notes maturing 5 June 2056, eligible as Solvency II Tier 2 capital. The notes pay 4.510% annually until 5 June 2036, then 3-month EURIBOR plus a margin quarterly, with possible interest deferral. Moody’s rates them A3. Proceeds will fund general purposes and a concurrent EUR 250 million tender for 2047 notes; settlement expected 5 June 2026.

$SCORMedAI 9/10

SCOR announces the launch of a cash tender offer and its intention to issue new subordinated notes

SCOR SE said it launched a cash tender offer to buy EUR 250m Fixed to Reset Subordinated Notes due 2047 (ISIN FR0012770063; EUR 250m outstanding) and EUR 500m Fixed to Reset Subordinated Notes due 2048 (ISIN FR0013179314; EUR 500m outstanding). The offer runs 27 May–3 June 2026. SCOR also intends to issue new Tier 2-eligible subordinated notes, with proceeds funding the tender, subject to market conditions.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.